• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外侧隔核中的 GLP-1R 阳性神经元介导利拉鲁肽在小鼠中的摄食抑制和体重降低作用。

GLP-1R-positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice.

机构信息

Shenzhen Key Laboratory of Drug Addiction, Shenzhen Neher Neural Plasticity Laboratory, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, China.

出版信息

J Clin Invest. 2024 Sep 3;134(17):e178239. doi: 10.1172/JCI178239.

DOI:10.1172/JCI178239
PMID:39225090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11364389/
Abstract

Liraglutide, a glucagon-like peptide-1 (GLP-1) analog, is approved for obesity treatment, but the specific neuronal sites that contribute to its therapeutic effects remain elusive. Here, we show that GLP-1 receptor-positive (GLP-1R-positive) neurons in the lateral septum (LSGLP-1R) play a critical role in mediating the anorectic and weight-loss effects of liraglutide. LSGLP-1R neurons were robustly activated by liraglutide, and chemogenetic activation of these neurons dramatically suppressed feeding. Targeted knockdown of GLP-1 receptors within the LS, but not in the hypothalamus, substantially attenuated liraglutide's ability to inhibit feeding and lower body weight. The activity of LSGLP-1R neurons rapidly decreased during naturalistic feeding episodes, while synaptic inactivation of LSGLP-1R neurons diminished the anorexic effects triggered by liraglutide. Together, these findings offer critical insights into the functional role of LSGLP-1R neurons in the physiological regulation of energy homeostasis and delineate their instrumental role in mediating the pharmacological efficacy of liraglutide.

摘要

利拉鲁肽是一种胰高血糖素样肽-1(GLP-1)类似物,已被批准用于肥胖症治疗,但促进其治疗效果的确切神经元位置仍难以捉摸。在这里,我们发现侧隔核(LSGLP-1R)中的 GLP-1 受体阳性(GLP-1R-阳性)神经元在介导利拉鲁肽的厌食和减肥作用方面发挥着关键作用。利拉鲁肽能强烈激活 LSGLP-1R 神经元,而这些神经元的化学遗传激活则显著抑制进食。靶向敲低 LS 中的 GLP-1 受体,但不在下丘脑,极大地削弱了利拉鲁肽抑制进食和降低体重的能力。在自然进食过程中,LSGLP-1R 神经元的活性迅速下降,而 LSGLP-1R 神经元的突触失活则减弱了利拉鲁肽引发的厌食作用。总之,这些发现为 LSGLP-1R 神经元在能量平衡的生理调节中的功能作用提供了重要的见解,并描绘了它们在介导利拉鲁肽的药理学疗效中的重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/ba7214f2b011/jci-134-178239-g040.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/39d8f234d475/jci-134-178239-g036.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/32fc8caface9/jci-134-178239-g037.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/2c96efe1901a/jci-134-178239-g038.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/9931289d7869/jci-134-178239-g039.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/ba7214f2b011/jci-134-178239-g040.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/39d8f234d475/jci-134-178239-g036.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/32fc8caface9/jci-134-178239-g037.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/2c96efe1901a/jci-134-178239-g038.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/9931289d7869/jci-134-178239-g039.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce9/11364389/ba7214f2b011/jci-134-178239-g040.jpg

相似文献

1
GLP-1R-positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice.外侧隔核中的 GLP-1R 阳性神经元介导利拉鲁肽在小鼠中的摄食抑制和体重降低作用。
J Clin Invest. 2024 Sep 3;134(17):e178239. doi: 10.1172/JCI178239.
2
Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons.利拉鲁肽通过表达胰高血糖素样肽-1 受体的谷氨酸能神经元调节食欲和体重。
Diabetes. 2018 Aug;67(8):1538-1548. doi: 10.2337/db17-1385. Epub 2018 May 18.
3
GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats.孤束核中的 GABA 神经元表达 GLP-1 受体,并介导利拉鲁肽对大鼠的摄食抑制作用。
Sci Transl Med. 2020 Mar 4;12(533). doi: 10.1126/scitranslmed.aay8071.
4
The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice.下丘脑胰高血糖素样肽-1受体对小鼠能量平衡和葡萄糖稳态的调节是充分但非必要的。
Diabetes. 2017 Feb;66(2):372-384. doi: 10.2337/db16-1102. Epub 2016 Dec 1.
5
Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.外周和中枢 GLP-1 受体群体介导了外周给予的 GLP-1 受体激动剂利拉鲁肽和 exendin-4 的厌食作用。
Endocrinology. 2011 Aug;152(8):3103-12. doi: 10.1210/en.2011-0174. Epub 2011 Jun 21.
6
Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight.胰高血糖素样肽-1及其类似物作用于中缝背核并调节中枢5-羟色胺以降低食欲和体重。
Diabetes. 2017 Apr;66(4):1062-1073. doi: 10.2337/db16-0755. Epub 2017 Jan 5.
7
Long-acting glucagon-like peptide-1 receptor agonists have direct access to and effects on pro-opiomelanocortin/cocaine- and amphetamine-stimulated transcript neurons in the mouse hypothalamus.长效胰高血糖素样肽-1 受体激动剂可直接作用于小鼠下丘脑的 pro-opiomelanocortin/可卡因-安非他命转录神经元,并产生影响。
J Diabetes Investig. 2016 Apr;7 Suppl 1(Suppl 1):56-63. doi: 10.1111/jdi.12463. Epub 2016 Apr 18.
8
Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation.GLP-1 受体激动剂的厌食和厌恶作用是由脑干胆囊收缩素神经元介导的,并受 GIP 受体激活的调节。
Mol Metab. 2022 Jan;55:101407. doi: 10.1016/j.molmet.2021.101407. Epub 2021 Nov 26.
9
Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance.星形胶质细胞调节胰高血糖素样肽-1受体介导的能量平衡效应。
J Neurosci. 2016 Mar 23;36(12):3531-40. doi: 10.1523/JNEUROSCI.3579-15.2016.
10
GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.GDF15 与利拉鲁肽协同作用,但不是减肥手术诱导小鼠体重减轻所必需的。
Mol Metab. 2019 Mar;21:13-21. doi: 10.1016/j.molmet.2019.01.003. Epub 2019 Jan 14.

引用本文的文献

1
Mechanisms of glucagon-like-peptide 1 in the brain beyond metabolic effects.胰高血糖素样肽1在大脑中的作用机制:超越代谢效应
Ann Pediatr Endocrinol Metab. 2025 Aug;30(4):165-174. doi: 10.6065/apem.2448320.160. Epub 2025 Aug 31.
2
GLP-1R associates with VAPB and SPHKAP at ERMCSs to regulate β-cell mitochondrial remodelling and function.胰高血糖素样肽-1受体(GLP-1R)在内质网-线粒体接触位点(ERMCSs)与VAPB和SPHKAP结合,以调节β细胞线粒体重塑和功能。
bioRxiv. 2025 Jul 20:2024.04.28.591531. doi: 10.1101/2024.04.28.591531.
3
Research on the effects of GLP-1 receptor agonists in treating cognitive dysfunction and gait disorders in elderly patients with diabetes.

本文引用的文献

1
The locus coeruleus contributes to the anorectic, nausea, and autonomic physiological effects of glucagon-like peptide-1.蓝斑核参与了胰高血糖素样肽-1 的厌食、恶心和自主生理效应。
Sci Adv. 2023 Sep 22;9(38):eadh0980. doi: 10.1126/sciadv.adh0980. Epub 2023 Sep 20.
2
A circuit from lateral septum neurotensin neurons to tuberal nucleus controls hedonic feeding.外侧隔核神经降压素神经元至结节核的回路控制享乐性进食。
Mol Psychiatry. 2022 Dec;27(12):4843-4860. doi: 10.1038/s41380-022-01742-0. Epub 2022 Aug 26.
3
Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions.
胰高血糖素样肽-1受体激动剂治疗老年糖尿病患者认知功能障碍和步态障碍的效果研究。
Front Pharmacol. 2025 Jun 24;16:1607443. doi: 10.3389/fphar.2025.1607443. eCollection 2025.
4
GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity.胰高血糖素样肽-1/胰高血糖素样肽-1受体轴:从代谢(肥胖症和2型糖尿病)到免疫
Open Biol. 2025 Jan;15(7):240303. doi: 10.1098/rsob.240303. Epub 2025 Jul 2.
5
Uncovering the role of Gpr45 in obesity regulation.揭示Gpr45在肥胖调节中的作用。
Mol Metab. 2025 May 29;98:102174. doi: 10.1016/j.molmet.2025.102174.
6
Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies.胰高血糖素样肽-1与下丘脑对饱腹感的调节:来自人类和动物研究的认知与神经学见解
Diabetes Metab J. 2025 May;49(3):333-347. doi: 10.4093/dmj.2025.0106. Epub 2025 May 1.
7
An inhibitory GLP-1 circuit in the lateral septum modulates reward processing and alcohol intake in rodents.外侧隔区中的抑制性胰高血糖素样肽-1回路调节啮齿动物的奖赏处理和酒精摄入。
EBioMedicine. 2025 May;115:105684. doi: 10.1016/j.ebiom.2025.105684. Epub 2025 Apr 17.
8
Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology.深入了解胰高血糖素样肽-1、二肽基肽酶-4和钠-葡萄糖协同转运蛋白2在心血管、肾脏和代谢病理生理学交叉点的作用
Cells. 2025 Mar 6;14(5):387. doi: 10.3390/cells14050387.
9
A single dorsal vagal complex circuit mediates the aversive and anorectic responses to GLP1R agonists.单一的迷走神经背侧复合体回路介导对胰高血糖素样肽-1受体激动剂的厌恶和厌食反应。
bioRxiv. 2025 Jan 24:2025.01.21.634167. doi: 10.1101/2025.01.21.634167.
10
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala.通过中央杏仁核整合胰高血糖素样肽1受体的作用
Endocrinology. 2025 Feb 5;166(3). doi: 10.1210/endocr/bqaf019.
成纤维细胞牵张感受器控制下丘脑利拉鲁肽摄取及其抗肥胖作用。
Cell Metab. 2022 Jul 5;34(7):1054-1063.e7. doi: 10.1016/j.cmet.2022.06.002. Epub 2022 Jun 17.
4
Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism.位于下丘脑背内侧核的葡萄糖感应胰高血糖素样肽-1 受体神经元调节葡萄糖代谢。
Sci Adv. 2022 Jun 10;8(23):eabn5345. doi: 10.1126/sciadv.abn5345. Epub 2022 Jun 8.
5
Anti-obesity drug discovery: advances and challenges.抗肥胖药物的发现:进展与挑战。
Nat Rev Drug Discov. 2022 Mar;21(3):201-223. doi: 10.1038/s41573-021-00337-8. Epub 2021 Nov 23.
6
Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?胰高血糖素样肽-1 在糖尿病治疗中的作用:能否在不引起恶心和呕吐的情况下实现血糖控制?
Br J Pharmacol. 2022 Feb;179(4):542-556. doi: 10.1111/bph.15647. Epub 2021 Sep 14.
7
Central and peripheral GLP-1 systems independently suppress eating.中枢和外周 GLP-1 系统独立地抑制摄食。
Nat Metab. 2021 Feb;3(2):258-273. doi: 10.1038/s42255-021-00344-4. Epub 2021 Feb 15.
8
A limbic circuit selectively links active escape to food suppression.边缘回路选择性地将主动逃避与食物抑制联系起来。
Elife. 2020 Sep 7;9:e58894. doi: 10.7554/eLife.58894.
9
GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats.孤束核中的 GABA 神经元表达 GLP-1 受体,并介导利拉鲁肽对大鼠的摄食抑制作用。
Sci Transl Med. 2020 Mar 4;12(533). doi: 10.1126/scitranslmed.aay8071.
10
The Discovery and Development of Liraglutide and Semaglutide.利拉鲁肽和司美格鲁肽的发现与研发
Front Endocrinol (Lausanne). 2019 Apr 12;10:155. doi: 10.3389/fendo.2019.00155. eCollection 2019.